Alpha Teknova, Inc. (TKNO)
USD 5.67
(1.43%)
USD 5.67
(1.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -25.53 Million USD | -407.75% |
| 2022 | -25.69 Million USD | 46.39% |
| 2021 | -9.12 Million USD | -236.05% |
| 2020 | 6.7 Million USD | 2978.54% |
| 2019 | -233 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -5.05 Million USD | 22.35% |
| 2024 Q2 | -5.1 Million USD | 45.29% |
| 2023 Q2 | -1.31 Million USD | 83.24% |
| 2023 Q1 | -7.81 Million USD | -57.36% |
| 2023 FY | - USD | -407.75% |
| 2023 Q4 | -7.07 Million USD | 19.22% |
| 2023 Q3 | -8.76 Million USD | -568.85% |
| 2022 Q2 | -5.83 Million USD | -14.57% |
| 2022 FY | - USD | 46.39% |
| 2022 Q1 | -5.09 Million USD | -27.81% |
| 2022 Q3 | 11 Million USD | 288.57% |
| 2022 Q4 | -4.96 Million USD | -145.15% |
| 2021 Q4 | -3.98 Million USD | -26.88% |
| 2021 Q1 | -176 Thousand USD | -112.88% |
| 2021 FY | - USD | -236.05% |
| 2021 Q2 | -1.82 Million USD | -937.5% |
| 2021 Q3 | -3.14 Million USD | -71.96% |
| 2020 Q1 | 1.46 Million USD | 0.0% |
| 2020 FY | - USD | 2978.54% |
| 2020 Q4 | 1.36 Million USD | -49.29% |
| 2020 Q3 | 2.69 Million USD | 127.92% |
| 2020 Q2 | 1.18 Million USD | -19.32% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 108.283% |
| Embecta Corp. | 245.4 Million USD | 110.407% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 123.362% |
| Dynavax Technologies Corporation | 9.66 Million USD | 364.215% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 82.986% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 115.678% |
| PainReform Ltd. | -9.56 Million USD | -166.893% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 2260.66% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -567.788% |
| SCYNEXIS, Inc. | 73.47 Million USD | 134.757% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -986.299% |
| Cosmos Health Inc. | -17.06 Million USD | -49.685% |
| Journey Medical Corporation | 1.92 Million USD | 1429.464% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -567.788% |
| Safety Shot Inc | -12.18 Million USD | -109.591% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 83.923% |
| Bright Green Corporation | - USD | Infinity% |
| Procaps Group, S.A. | 104.02 Million USD | 124.55% |
| Theratechnologies Inc. | -10.31 Million USD | -147.644% |
| Harrow Health, Inc. | 9.72 Million USD | 362.666% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | -464.398% |
| Biofrontera Inc. | -18.45 Million USD | -38.4% |
| DURECT Corporation | -24.68 Million USD | -3.464% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 125.991% |
| Cronos Group Inc. | -72.14 Million USD | 64.602% |
| OptiNose, Inc. | -15.55 Million USD | -64.206% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 97.239% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 29.22% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 197.232% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 170.881% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | -551.114% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -3492.741% |
| Radius Health, Inc. | 38.31 Million USD | 166.664% |
| Universe Pharmaceuticals INC | -3.21 Million USD | -694.353% |
| ProPhase Labs, Inc. | -14.82 Million USD | -72.247% |
| Phibro Animal Health Corporation | 84.6 Million USD | 130.185% |
| Procaps Group S.A. | 104.02 Million USD | 124.55% |
| Alvotech | -484.86 Million USD | 94.733% |
| TherapeuticsMD, Inc. | -8.4 Million USD | -204.0% |
| Viatris Inc. | 3.51 Billion USD | 100.726% |
| Rockwell Medical, Inc. | -4.69 Million USD | -444.078% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -2423.617% |
| SIGA Technologies, Inc. | 84.15 Million USD | 130.346% |
| Tilray Brands, Inc. | -72.84 Million USD | 64.94% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 3245.197% |
| Shineco, Inc. | -26.55 Million USD | 3.822% |
| PetIQ, Inc. | 81.48 Million USD | 131.342% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | -605.96% |
| Incannex Healthcare Limited | -18.5 Million USD | -38.019% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 106.138% |
| Alimera Sciences, Inc. | 7.27 Million USD | 451.003% |
| Silver Spike Investment Corp. | 7.34 Million USD | 447.938% |
| Assertio Holdings, Inc. | -222.44 Million USD | 88.519% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | -539.971% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | -506.358% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | -51.982% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | -27.499% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 82.874% |
| Hempacco Co., Inc. | -12.77 Million USD | -99.941% |
| Talphera, Inc. | -9.84 Million USD | -159.49% |
| Alvotech | -484.86 Million USD | 94.733% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 132.953% |
| Lantheus Holdings, Inc. | 491 Million USD | 105.201% |
| Currenc Group, Inc. | -1.9 Million USD | -1243.752% |
| Kamada Ltd. | 21.53 Million USD | 218.598% |
| Indivior PLC | 66 Million USD | 138.695% |
| Evoke Pharma, Inc. | -7.29 Million USD | -250.219% |
| Flora Growth Corp. | -45.87 Million USD | 44.323% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | -27.499% |
| Evolus, Inc. | -41.81 Million USD | 38.917% |
| HUTCHMED (China) Limited | 25.52 Million USD | 200.043% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 110.577% |
| Akanda Corp. | -27.73 Million USD | 7.92% |